ANTIBODY-INDUCED KILLING INVIVO OF L1210-MTX-R CELLS QUANTITATED IN PASSIVELY IMMUNIZED MICE WITH IODODEOXYURIDINE-I-131-LABELED CELLS AND WHOLE-BODY MEASUREMENT OF RETAINED RADIOACTIVITY
- 1 January 1976
- journal article
- research article
- Vol. 117 (3) , 822-829
Abstract
The killing of the LR subline of the DBA/2J leukemia L1210/MTX by passive antibody was followed in vivo with 131I-iododeoxyuridine-labeled cells and whole-body measurement of retained radioactivity. The in vivo killing of LR cells was proportional to the in vitro 2-mercaptoethanol resistant [antibody] titer, independent of the complement system and radioresistant. Although a large percentage of the leukemic cells were killed in passively immunized mice, the protective effect of the passive antiserum was dependent on the active immune response of the host.This publication has 9 references indexed in Scilit:
- A Single Gene Controlling Hemolytic Complement and a Serum Antigen in the MouseThe Journal of Immunology, 1964
- Immunochemical Studies of Human Serum Fractionated by Gel Filtration with Sephadex G-200Experimental Biology and Medicine, 1964
- DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO .I. CELL PROLIFERATION + DEATH AS MEASURED BY INCORPORATION + ELIMINATION OF IODODEOXYURIDINE1964
- Studies on the Mechanism of Immunological Enhancement of Tumor Homografts. 11. Effect of Isoantibodies on Various Tumor Cells2JNCI Journal of the National Cancer Institute, 1963
- IMMUNE MECHANISMS IN HOMOTRANSPLANTATION .1. ROLE OF SERUM ANTIBODY AND COMPLEMENT IN THE NEUTRALIZATION OF LYMPHOMA CELLS1960
- EFFECT OF ISOANTIBODIES INVIVO ON 3 DIFFERENT TRANSPLANTABLE NEOPLASMS IN MICE1959
- INCOMPATIBILITY REACTIONS TO TUMOR HOMOTRANSPLANTS WITH PARTICULAR REFERENCE TO THE ROLE OF THE TUMOR - A REVIEW1957
- Development of Resistance to Folic Acid Antagonists in a Transplantable Lymphoid LeukemiaExperimental Biology and Medicine, 1950
- Observations on the Effect of a Folic-Acid Antagonist on Transplantable Lymphoid Leukemias in Mice2JNCI Journal of the National Cancer Institute, 1949